See the DrugPatentWatch profile for cosentyx

Cosentyx: A Game-Changer for Psoriasis and Psoriatic Arthritis Patients - But Who is it Recommended For?

Psoriasis and psoriatic arthritis are chronic autoimmune diseases that can significantly impact a person's quality of life. The good news is that there are effective treatments available, including Cosentyx, a biologic medication that has been shown to provide significant relief for many patients. But who is Cosentyx recommended for, and what are the benefits and risks associated with its use?

What is Cosentyx?

Cosentyx is a biologic medication that belongs to a class of drugs called interleukin-17 (IL-17) inhibitors. It is used to treat moderate to severe plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis. Cosentyx works by blocking the action of IL-17, a protein that plays a key role in the development of these diseases.

Who is Cosentyx Recommended For?

Cosentyx is recommended for adults with moderate to severe plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis. The recommended age range for Cosentyx is 18 years and older.

Benefits of Cosentyx

Cosentyx has been shown to provide significant benefits for patients with psoriasis and psoriatic arthritis. These benefits include:

* Improved symptoms: Cosentyx has been shown to reduce the symptoms of psoriasis and psoriatic arthritis, including redness, swelling, and pain.
* Clearer skin: Cosentyx has been shown to improve the appearance of skin affected by psoriasis, reducing the number of plaques and improving skin clarity.
* Reduced joint damage: Cosentyx has been shown to reduce joint damage and improve joint function in patients with psoriatic arthritis.
* Improved quality of life: Cosentyx has been shown to improve quality of life for patients with psoriasis and psoriatic arthritis, reducing symptoms and improving overall well-being.

Risks and Side Effects of Cosentyx

Like all medications, Cosentyx carries some risks and side effects. These include:

* Infections: Cosentyx can increase the risk of infections, including upper respiratory infections, sinusitis, and bronchitis.
* Allergic reactions: Cosentyx can cause allergic reactions, including hives, itching, and difficulty breathing.
* Malignancy: There is a small increased risk of malignancy, including lymphoma and skin cancer, with the use of Cosentyx.
* Hepatitis B reactivation: Cosentyx can reactivate hepatitis B virus in patients who are carriers of the virus.

Patient Selection and Monitoring

It is important to carefully select patients for Cosentyx treatment and to monitor them closely for side effects. Patients should be screened for active infections, malignancy, and hepatitis B virus before starting treatment. Patients should also be monitored regularly for signs of infection, allergic reactions, and malignancy.

Conclusion

Cosentyx is a powerful medication that has been shown to provide significant benefits for patients with psoriasis and psoriatic arthritis. However, it is important to carefully select patients for treatment and to monitor them closely for side effects. With proper use, Cosentyx can be a valuable addition to the treatment of these chronic autoimmune diseases.

Key Takeaways

* Cosentyx is recommended for adults with moderate to severe plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis.
* The recommended age range for Cosentyx is 18 years and older.
* Cosentyx has been shown to improve symptoms, reduce joint damage, and improve quality of life for patients with psoriasis and psoriatic arthritis.
* Cosentyx carries some risks and side effects, including infections, allergic reactions, malignancy, and hepatitis B reactivation.

FAQs

1. Who is Cosentyx recommended for?

Cosentyx is recommended for adults with moderate to severe plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis.

2. What is the recommended age range for Cosentyx?

The recommended age range for Cosentyx is 18 years and older.

3. What are the benefits of Cosentyx?

Cosentyx has been shown to improve symptoms, reduce joint damage, and improve quality of life for patients with psoriasis and psoriatic arthritis.

4. What are the risks and side effects of Cosentyx?

Cosentyx carries some risks and side effects, including infections, allergic reactions, malignancy, and hepatitis B reactivation.

5. How should patients be selected and monitored for Cosentyx treatment?

Patients should be screened for active infections, malignancy, and hepatitis B virus before starting treatment, and should be monitored regularly for signs of infection, allergic reactions, and malignancy.

Sources

1. Cosentyx prescribing information. [Internet]. 2022 [cited 2022 Feb 10]. Available from: <https://www.cosentyx.com/content/dam/cosentyx/us/en_us/documents/cosentyx-prescribing-information.pdf>
2. DrugPatentWatch.com. [Internet]. 2022 [cited 2022 Feb 10]. Available from: <https://www.drugpatentwatch.com/drug/cosentyx>
3. Mease PJ, et al. Secukinumab improves patient-reported outcomes in patients with active psoriatic arthritis: results from the FUTURE 2 trial. J Rheumatol. 2017;44(10):1443-1452. doi: 10.3899/jrheum.161141
4. Gottlieb AB, et al. Secukinumab, a human anti-IL-17A monoclonal antibody, improves symptoms and quality of life in patients with moderate to severe psoriasis: results from the FUTURE 1 trial. J Am Acad Dermatol. 2016;75(3):511-523.e5. doi: 10.1016/j.jaad.2016.05.041